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Engineering the human cornea
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Currently available synthetic artificial corneas (keratoprostheses) present with severe
limitations for cornea grafting. European scientists proposed an alternative in vitro
system which is expected to revolutionise cornea transplantation.
HEALTH
Diseases affecting the cornea are on the rise, with over 10 million people being
affected worldwide. Current treatment approaches mainly involve transplantation of
donor corneas. This is, however, hampered by the shortage of donors, the
widespread use of corrective surgery, which renders corneas unsuitable for grafting,
and the increasing risk of transmissible diseases. 
 
Responding to the urgent need to develop new forms of corneal replacements, the
EU-funded ‘Three-dimensional reconstruction of human corneas by tissue
engineering’ (Cornea Engineering) project proposed to develop a human cornea in
vitro. This would serve for corneal grafting and as an alternative to animal models for
cosmetics and pharmacotoxicity testing. 
 
The innovation of the Cornea Engineering approach relied on the production of three-
dimensional (3D) cell scaffolds resembling the natural extracellular matrix (ECM). To
do so, scientists developed protocols for the use of recombinant human ECM
proteins and their processing enzymes to support the growth of the different cell
types found in the cornea. Implementation of the acquired knowledge led to the
development of a hemi-cornea using human epithelial and stroma cells which would
serve as an in vitro alternative to animal toxicity testing. 
 
By studying the roles of extracellular enzymes and cell-matrix interactions in corneal
structure and repair, partners succeeded in identifying new molecular mechanisms
controlling the phenotype of stem cells. These findings enabled them to perform
clinical trials using stem cell-derived epithelial cells. 
 
The Cornea Engineering project succeeded in unravelling the matrix-cell interactions
which are essential for optimal cornea tissue reconstruction, culminating in the
development of full depth in vitro corneas. The reconstruction of the human cornea
represents a real breakthrough, offering the opportunity for patients with diseased or
damaged corneas to have them replaced by tissue-engineered human corneal
equivalents.
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